Literature DB >> 26224611

One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips.

Thomas Ilchmann1, Werner Zimmerli2, Peter Emil Ochsner3, Bernhard Kessler2, Lukas Zwicky4, Peter Graber2, Martin Clauss3.   

Abstract

PURPOSE: There are various options for treating periprosthetic joint infection (PJI). Two-stage exchange has traditionally been the gold standard. However, if the appropriate surgical intervention is chosen according to a rational algorithm, the outcome is similar when using all types of interventions. In an observational cohort study, the outcome of patients with PJI after hip replacement treated with one-stage revision was analysed.
METHODS: All patients fulfilling all criteria for one-stage exchange according to the Infectious Diseases Society of America (IDSA) guidelines and six without preoperative identification of a microorganism were included. Implant removal, debridement and cemented or uncemented reimplantations were performed in a single intervention. If a cemented device was implanted, commercially available gentamicin cement was used in all cases. Antibiotic treatment was administered intravenously for at least 2 weeks, followed by oral therapy for a total duration of 3 months. Patients had standardised clinical and radiological follow-up visits.
RESULTS: Between 1996 and 2011, 38 patients (39 hips) were treated with a one-stage procedure and followed for at least 2 years. Coagulase-negative staphylococci were the most frequent pathogens, and polymicrobial infection was observed in five cases. In 25 hips, an uncemented revision stem was implanted, and 37 hips received an acetabular reinforcement ring. The mean follow-up was 6.6 (2.0-15.1) years. No patient had persistent, recurrent or new infection. There were four stem revisions for aseptic loosening. The mean Harris Hip Score was 81 points (26-99) at the final follow-up.
CONCLUSIONS: Excellent cure rate and function seen in our study suggest that one-stage exchange is a safe procedure, even without local antibiotic treatment, provided that the patient has no sinus tract or severe soft tissue damage, no major bone grafting is required and the microorganism is susceptible to orally administered agents with high bioavailability.

Entities:  

Keywords:  Hip arthroplasty; Hip replacement; Infection; One-stage; Treatment; Uncemented

Mesh:

Substances:

Year:  2015        PMID: 26224611     DOI: 10.1007/s00264-015-2833-4

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  25 in total

1.  Comparison of one-stage revision with antibiotic cement versus two-stage revision results for infected total hip arthroplasty.

Authors:  Ho-Rim Choi; Young-Min Kwon; Andrew A Freiberg; Henrik Malchau
Journal:  J Arthroplasty       Date:  2013-08-20       Impact factor: 4.757

2.  Prosthetic joint infection following total hip replacement: results of one-stage versus two-stage exchange.

Authors:  Matthias Wolf; Heimo Clar; Jörg Friesenbichler; Gerold Schwantzer; Gerwin Bernhardt; Gerald Gruber; Mathias Glehr; Andreas Leithner; Patrick Sadoghi
Journal:  Int Orthop       Date:  2014-03-18       Impact factor: 3.075

3.  Femoral revision with the Wagner tapered stem: a ten- to 15-year follow-up study.

Authors:  D Regis; A Sandri; I Bonetti; M Braggion; P Bartolozzi
Journal:  J Bone Joint Surg Br       Date:  2011-10

4.  Low rate of infection control in enterococcal periprosthetic joint infections.

Authors:  Mohammad R Rasouli; Mohan S Tripathi; Robert Kenyon; Nathan Wetters; Craig J Della Valle; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

5.  Propionibacterium spp. in prosthetic joint infections: a diagnostic challenge.

Authors:  Björn Zappe; Susanne Graf; Peter E Ochsner; Werner Zimmerli; Parham Sendi
Journal:  Arch Orthop Trauma Surg       Date:  2007-09-15       Impact factor: 3.067

6.  Management of infection associated with total hip arthroplasty according to a treatment algorithm.

Authors:  S G Giulieri; P Graber; P E Ochsner; W Zimmerli
Journal:  Infection       Date:  2004-08       Impact factor: 3.553

7.  Acetabular reconstruction with the Burch-Schneider ring: an EBRA analysis of 40 cup revisions.

Authors:  Thomas Ilchmann; Jan Philipp Gelzer; Eugen Winter; Kuno Weise
Journal:  Acta Orthop       Date:  2006-02       Impact factor: 3.717

8.  Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty.

Authors:  Mark F Schinsky; Craig J Della Valle; Scott M Sporer; Wayne G Paprosky
Journal:  J Bone Joint Surg Am       Date:  2008-09       Impact factor: 5.284

9.  Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis.

Authors:  Jeppe Lange; Anders Troelsen; Reimar W Thomsen; Kjeld Søballe
Journal:  Clin Epidemiol       Date:  2012-03-27       Impact factor: 4.790

10.  Increasing risk of prosthetic joint infection after total hip arthroplasty.

Authors:  Håvard Dale; Anne M Fenstad; Geir Hallan; Leif I Havelin; Ove Furnes; Søren Overgaard; Alma B Pedersen; Johan Kärrholm; Göran Garellick; Pekka Pulkkinen; Antti Eskelinen; Keijo Mäkelä; Lars B Engesæter
Journal:  Acta Orthop       Date:  2012-10       Impact factor: 3.717

View more
  19 in total

Review 1.  What are the risk factors for post-operative infection after hip hemiarthroplasty? Systematic review of literature.

Authors:  Thibaut Noailles; Kévin Brulefert; Antoine Chalopin; Pierre Marie Longis; François Gouin
Journal:  Int Orthop       Date:  2015-11-27       Impact factor: 3.075

2.  Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers.

Authors:  Rashid Tikhilov; Svetlana Bozhkova; Alexey Denisov; Dmitry Labutin; Igor Shubnyakov; Vadim Razorenov; Vasilii Artyukh; Olga Klitsenko
Journal:  Int Orthop       Date:  2015-12-19       Impact factor: 3.075

3.  CORR Insights®: Late Reinfection May Recur More Than 5 Years After Reimplantation of THA and TKA: Analysis of Pathogen Factors.

Authors:  José Cordero-Ampuero
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

Review 4.  Poor Prognosis of Patients Treated for Periprosthetic Joint Infection.

Authors:  Cynthia A Kahlenberg; Alexia Hernandez-Soria; Michael B Cross
Journal:  HSS J       Date:  2016-06-01

5.  Single-stage Acetabular Revision During Two-stage THA Revision for Infection is Effective in Selected Patients.

Authors:  Bernd Fink; Michael Schlumberger; Damian Oremek
Journal:  Clin Orthop Relat Res       Date:  2017-03-28       Impact factor: 4.176

6.  Is a preoperative pathogen detection a prerequisite before undergoing one-stage exchange for prosthetic joint infection of the hip?

Authors:  Daniel Karczewski; Yannick Seutz; Christian Hipfl; Doruk Akgün; Octavian Andronic; Carsten Perka; Sebastian Hardt
Journal:  Arch Orthop Trauma Surg       Date:  2022-05-04       Impact factor: 3.067

7.  Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up.

Authors:  Baochao Ji; Boyong Xu; Wentao Guo; Aili Rehei; Wenbo Mu; Desheng Yang; Li Cao
Journal:  Int Orthop       Date:  2016-09-20       Impact factor: 3.075

8.  Blood loss and allogeneic transfusion for surgical treatment of periprosthetic joint infection: a comparison of one- vs. two-stage exchange total hip arthroplasty.

Authors:  Ahmad Shoib Sharqzad; Camila Cavalheiro; Akos Zahar; Christian Lausmann; Thorsten Gehrke; Daniel Kendoff; Javad Parvizi; Mustafa Citak
Journal:  Int Orthop       Date:  2018-09-05       Impact factor: 3.075

9.  One-stage Revision With Catheter Infusion of Intraarticular Antibiotics Successfully Treats Infected THA.

Authors:  Leo A Whiteside; M E Roy
Journal:  Clin Orthop Relat Res       Date:  2017-02       Impact factor: 4.176

10.  Adherence to a reliable PJI diagnostic protocol minimizes unsuspected positive cultures rate.

Authors:  Daniel Pérez-Prieto; Pedro Hinarejos; Albert Alier; Lluïsa Sorlí; Santos Martínez; Lluís Puig; Juan C Monllau
Journal:  BMC Musculoskelet Disord       Date:  2021-08-02       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.